Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Health Catalyst (HCAT) Receivables - Other (2018 - 2025)

Health Catalyst's Receivables - Other history spans 8 years, with the latest figure at $10.1 million for Q4 2025.

  • For Q4 2025, Receivables - Other fell 14.41% year-over-year to $10.1 million; the TTM value through Dec 2025 reached $10.1 million, down 14.41%, while the annual FY2025 figure was $10.1 million, 14.41% down from the prior year.
  • Receivables - Other reached $10.1 million in Q4 2025 per HCAT's latest filing, up from $8.5 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $11.8 million in Q4 2024 to a low of $500000.0 in Q2 2022.
  • Average Receivables - Other over 5 years is $4.1 million, with a median of $2.4 million recorded in 2023.
  • Peak YoY movement for Receivables - Other: plummeted 58.33% in 2022, then surged 422.22% in 2023.
  • A 5-year view of Receivables - Other shows it stood at $800000.0 in 2021, then grew by 12.5% to $900000.0 in 2022, then soared by 422.22% to $4.7 million in 2023, then skyrocketed by 151.06% to $11.8 million in 2024, then dropped by 14.41% to $10.1 million in 2025.
  • Per Business Quant, the three most recent readings for HCAT's Receivables - Other are $10.1 million (Q4 2025), $8.5 million (Q3 2025), and $8.7 million (Q2 2025).